Xueying An

597 total citations
25 papers, 448 citations indexed

About

Xueying An is a scholar working on Molecular Biology, Immunology and Biomedical Engineering. According to data from OpenAlex, Xueying An has authored 25 papers receiving a total of 448 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 4 papers in Immunology and 4 papers in Biomedical Engineering. Recurrent topics in Xueying An's work include RNA Interference and Gene Delivery (4 papers), Osteoarthritis Treatment and Mechanisms (3 papers) and Cell Adhesion Molecules Research (3 papers). Xueying An is often cited by papers focused on RNA Interference and Gene Delivery (4 papers), Osteoarthritis Treatment and Mechanisms (3 papers) and Cell Adhesion Molecules Research (3 papers). Xueying An collaborates with scholars based in China, United States and Czechia. Xueying An's co-authors include Xinghai Ning, Qing Jiang, Yurui Xu, Xia Meng, Jianmei Chen, Leilei Guo, Yanfeng Liu, Qinhe Pan, Duoyu Lin and Xiaolei Fan and has published in prestigious journals such as Analytical Chemistry, Journal of Agricultural and Food Chemistry and ACS Applied Materials & Interfaces.

In The Last Decade

Xueying An

21 papers receiving 445 citations

Peers

Countries citing papers authored by Xueying An

Since Specialization

Citations

This map shows the geographic impact of Xueying An's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xueying An with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xueying An more than expected).

Fields of papers citing papers by Xueying An

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xueying An. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xueying An. The network helps show where Xueying An may publish in the future.

Co-authorship network of co-authors of Xueying An

This figure shows the co-authorship network connecting the top 25 collaborators of Xueying An. A scholar is included among the top collaborators of Xueying An based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xueying An. Xueying An is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Dynamic Fibrous Hydrogels for Stem Cell Homing and In Situ Bone Regeneration 2025 ·Advanced Science ·Jianmei Chen, Meiling Su, Xinyu Wu, (unknown), (unknown), Pinghu Zhang, Xueying An, Zongguang Liu	0
2	Lignin-Based Therapeutics: Targeting Mitochondrial Pathways in Osteosarcoma 2025 ·Journal of Agricultural and Food Chemistry ·Yilin Wang, Sheng Zhou, (unknown), Xueying An, Wenjuan Wu, (unknown), Chaofeng Zhang, Sehrish Manan, Peng Wang, Yongcan Jin	0
3	Targeted Blockage of Pathological Extracellular Vesicles and Particles From Fibroblast‐Like Synoviocytes for Osteoarthritis Relief: Proteomic Analysis and Cellular Effect 2025 ·Journal of Extracellular Vesicles ·Bin Liu, (unknown), Tao Shen, Ben Yu, Wenshu Wu, Yong Shi, Xueying An, Rui Peng, (unknown), Wang Gong, Xiang Chen, Baosheng Guo, Qing Jiang	0
4	Functional Lignin with Enhanced Aliphatic Hydroxyl and Carboxyl Groups to Attenuate Osteosarcoma Progression via Promoting Mitochondrial Dysfunction 2025 ·Biomacromolecules ·Yilin Wang, Yufeng Yuan, (unknown), (unknown), Xueying An, (unknown), Chaofeng Zhang, Sehrish Manan, Peng Wang, Yongcan Jin	0
5	CGA protects against experimental colitis by modulating host purine metabolism through the gut microbiota 2025 ·International Immunopharmacology ·Xiaolin Ye, Xueying An, (unknown), Yan Kong, S. M. Jia, Jie Wu	3
6	Enhanced SIRT3 expression restores mitochondrial quality control mechanism to reverse osteogenic impairment in type 2 diabetes mellitus 2025 ·Bone Research ·(unknown), Bin Liu, (unknown), Lin Yang, Rui Peng, (unknown), Xueying An, Yutian Wang, (unknown), Qing Jiang, Baosheng Guo	9
7	ShK‐modified UCMSCs Inhibit M1‐Like Macrophage Polarization and Alleviate Osteoarthritis Progression via PI3K/Akt Axis 2024 ·Advanced Science ·Wenshu Wu, Xueying An, Wang Gong, Lin Yang, Na Liu, Bin Liu, Baosheng Guo, Qing Jiang, Lan Li	9
8	Adhesive Nanoparticle‐in‐Microgel System with ROS Scavenging Capability and Hemostatic Activity for Postoperative Adhesion Prevention 2024 ·Small ·Jianmei Chen, Xueying An, Li Xu, Ya Gao, (unknown), Zongguang Liu	20
9	Long noncoding RNA TUG1 promotes malignant progression of osteosarcoma by enhancing ZBTB7C expression 2023 ·Biomedical Journal ·Xueying An, Wenshu Wu, (unknown), (unknown), (unknown), Jian Dong, Gong Wang, Bin Liu, Lin Yang, Yuze Ma, Xingquan Xu, Jianmei Chen, Wangsen Cao, Qing Jiang	3
10	Duo Cadherin‐Functionalized Microparticles Synergistically Induce Chondrogenesis and Cartilage Repair of Stem Cell Aggregates 2022 ·Advanced Healthcare Materials ·Xueping Wang, Xingquan Xu, Yan Zhang, Xueying An, Xue Zhang, Guoqiang Chen, Qing Jiang, Jun Yang	10
11	Network Pharmacology-Based Strategy for the Investigation of the Anti-Osteoporosis Effects and Underlying Mechanism of Zhuangguguanjie Formulation 2021 ·Frontiers in Pharmacology ·Wang Gong, Xingren Chen, Tianshu Shi, Xiaoyan Shao, Xueying An, Jianghui Qin, Xiang Chen, Qing Jiang, Baosheng Guo	4
12	The Effect of Ball Milling Time on the Isolation of Lignin in the Cell Wall of Different Biomass 2021 ·Frontiers in Bioengineering and Biotechnology ·(unknown), Xueying An, Shilong Yang	21
13	Synthesis-temperature-regulated multi-enzyme-mimicking activities of ceria nanozymes 2021 ·Journal of Materials Chemistry B ·Xiaoli Liu, Jiangjiexing Wu, Quanyi Liu, Anqi Lin, Sirong Li, Yihong Zhang, Quan Wang, Tong Li, Xueying An, Zijun Zhou, Ming Yang, Hui Wei	48
14	Biochar Nanozyme from Silkworm Excrement for Scavenging Vapor-Phase Free Radicals in Cigarette Smoke 2021 ·ACS Applied Bio Materials ·Quanyi Liu, Sheng Zhao, Yihong Zhang, Xueying An, Quan Wang, Sirong Li, Anqi Lin, Yan Du, Hui Wei	10
15	Discovery and characterization of a novel peptide inhibitor against influenza neuraminidase 2020 ·RSC Medicinal Chemistry ·Jianmei Chen, Shujun Feng, Yurui Xu, Xinyu Huang, (unknown), Jiao Chen, Xueying An, Yu Zhang, Xinghai Ning	9
16	Ultrasound-responsive alkaline nanorobots for the treatment of lactic acidosis-mediated doxorubicin resistance 2020 ·Nanoscale ·Xia Meng, Yurui Xu, Qiangbing Lu, Lei Sun, Xueying An, (unknown), Jianmei Chen, Ya Gao, Yu Zhang, Xinghai Ning	32
17	In situ modification of ZIF-67 with multi-sulfonated dyes for great enhanced methylene blue adsorption via synergistic effect 2020 ·Microporous and Mesoporous Materials ·Yanfeng Liu, Duoyu Lin, Weiting Yang, Xueying An, (unknown), Xiaolei Fan, Qinhe Pan	64
18	A stimuli-responsive combination therapy for recovering p53-inactivation associated drug resistance 2019 ·Materials Science and Engineering C ·Leilei Guo, Yurui Xu, Anwei Zhou, (unknown), Lei Sun, Ya Gao, Jianmei Chen, Xue Shan, (unknown), Junliang Ge, Xueying An, Xiaoxuan Liu, Yu Zhang, Xinghai Ning	12
19	Integrin αvβ3-Specific Hydrocyanine for Cooperative Targeting of Glioblastoma with High Sensitivity and Specificity 2019 ·Analytical Chemistry ·Lei Zhang, Xia Meng, Xue Shan, Tingting Gu, (unknown), Shujun Feng, Xueying An, Jiao Chen, Qing Jiang, Xinghai Ning	13
20	Novel Gold Nanorod-Based HR1 Peptide Inhibitor for Middle East Respiratory Syndrome Coronavirus 2019 ·ACS Applied Materials & Interfaces ·Xinyu Huang, Meng Li, Yurui Xu, (unknown), Xia Meng, Xueying An, Lei Sun, Leilei Guo, Xue Shan, Junliang Ge, Jiao Chen, Yadong Luo, Heming Wu, Yu Zhang, Qing Jiang, Xinghai Ning	76

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact